TXNIP and Alzheimer disease: Previous studies have shown that TXNIP as an endogenous inhibitor of antioxidant thioredoxin was found to increase in AD patients and AD mouse models, and could be a key coordinator of different pathological processes (Tsubaki et al., 2020).